DRUG RETENTION AND REASONS FOR DISCONTINUATION OF BIOLOGICS AND JAK INHIBITORS IN PATIENTS WITH RHEUMATOID ARTHRITIS - THE ANSWER COHORT STUDY

被引：0

作者：

Ebina, K. ^{[1
,2
]}

Etani, Y. ^{[2
]}

Maeda, Y. ^{[3
]}

Okita, Y. ^{[3
]}

Hirao, M. ^{[4
]}

Yamamoto, W. ^{[5
]}

Hashimoto, M. ^{[6
]}

Murata, K. ^{[7
]}

Hara, R. ^{[8
,9
]}

Nagai, K. ^{[10
]}

Hiramatsu, Y. ^{[10
]}

Son, Y. ^{[11
]}

Amuro, H. ^{[11
]}

Fujii, T. ^{[7
]}

Okano, T. ^{[6
,12
]}

Ueda, Y. ^{[12
]}

Katayama, M. ^{[13
]}

Okano, T. ^{[6
,12
]}

Kumanogoh, A. ^{[3
]}

Okada, S. ^{[2
]}

Nakata, K. ^{[14
]}

机构：

[1] Osaka Univ, Grad Sch Med, Dept Musculoskeletal Regenerat Med, Osaka, Japan

[2] Osaka Univ, Dept Orthopaed Surg, Grad Sch Med, Suita, Osaka, Japan

[3] Osaka Univ, Dept Resp Med & Clin Immunol, Grad Sch Med, Suita, Osaka, Japan

[4] Osaka Minami Med Ctr, Dept Orthopaed Surg, Kawachi Nagano, Japan

[5] Kurashiki Sweet Hosp, Dept Hlth Informat Management, Kurashiki, Okayama, Japan

[6] Osaka Metropolitan Univ, Dept Clin Immunol, Osaka, Japan

[7] Kyoto Univ, Dept Adv Med Rheumat Dis, Kyoto, Japan

[8] Nara Med Univ, Rheumatol Clin, Kashihara, Nara, Japan

[9] Nara Med Univ, Dept Orthopaed Surg, Kashihara, Nara, Japan

[10] Osaka Med & Pharmaceut Univ, Dept Internal Med 4, Takatsuki, Osaka, Japan

[11] Kansai Med Univ, Dept Internal Med 1, Hirakata, Osaka, Japan

[12] Kobe Univ, Dept Rheumatol & Clin Immunol, Kobe, Hyogo, Japan

[13] Osaka Red Cross Hosp, Dept Rheumatol, Osaka, Japan

[14] Osaka Univ, Dept Hlth & Sport Sci, Grad Sch Med, Suita, Osaka, Japan

来源：

ANNALS OF THE RHEUMATIC DISEASES | 2023年 / 82卷

关键词：

Disease-modifying Drugs (DMARDs); Rheumatoid arthritis; Realworld-evidence;

D O I：

10.1136/annrheumdis-2023-eular.1135

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

POS0051

引用

页码：234 / 235

页数：2

共 50 条

[1] Drug retention and discontinuation reasons between seven biologics in patients with rheumatoid arthritis -The ANSWER cohort study-
Ebina, Kosuke
Hashimoto, Motomu
Yamamoto, Wataru
Ohnishi, Akira
Kabata, Daijiro
Hirano, Toru
Hara, Ryota
Katayame, Masaki
Yoshida, Shuzo
Nagai, Koji
Son, Yonsu
Amuro, Hideki
Akashi, Kengo
Fujimura, Takanori
Hirao, Makoto
Yamamoto, Keiichi
Shintani, Ayumi
Kumanogoh, Atsushi
Yoshikawa, Hideki
PLOS ONE, 2018, 13 (03):
[2] Drug retention of biologics and Janus kinase inhibitors in patients with rheumatoid arthritis: the ANSWER cohort study
Ebina, Kosuke
Etani, Yuki
Maeda, Yuichi
Okita, Yasutaka
Hirao, Makoto
Yamamoto, Wataru
Hashimoto, Motomu
Murata, Koichi
Hara, Ryota
Nagai, Koji
Hiramatsu, Yuri
Son, Yonsu
Amuro, Hideki
Fujii, Takayuki
Okano, Takaichi
Ueda, Yo
Katayama, Masaki
Okano, Tadashi
Tachibana, Shotaro
Hayashi, Shinya
Kumanogoh, Atsushi
Okada, Seiji
Nakata, Ken
RMD OPEN, 2023, 9 (03):
[3] Drug retention of secondary biologics or JAK inhibitors after tocilizumab or abatacept failure as first biologics in patients with rheumatoid arthritis -the ANSWER cohort study
Ebina, Kosuke
Hirano, Toru
Maeda, Yuichi
Yamamoto, Wataru
Hashimoto, Motomu
Murata, Koichi
Takeuchi, Tohru
Nagai, Koji
Son, Yonsu
Amuro, Hideki
Onishi, Akira
Jinno, Sadao
Hara, Ryota
Katayama, Masaki
Yamamoto, Keiichi
Kumanogoh, Atsushi
Hirao, Makoto
CLINICAL RHEUMATOLOGY, 2020, 39 (09) : 2563 - 2572
[4] DRUG RETENTION OF BIOLOGICS OR JAK INHIBITORS IN PATIENTS WITH DIFFICULT-TO-TREAT RHEUMATOID ARTHRITIS: RESULTS FROM THE ANSWER COHORT
Watanabe, R.
Okano, T.
Yamada, S.
Yamamoto, W.
Murata, K.
Murakami, K.
Ebina, K.
Maeda, Y.
Jinno, S.
Shirasugi, I.
Son, Y.
Amuro, H.
Katayama, M.
Hara, R.
Hata, K.
Yoshikawa, A.
Hashimoto, M.
ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 527 - 528
[5] Drug retention of secondary biologics or JAK inhibitors after tocilizumab or abatacept failure as first biologics in patients with rheumatoid arthritis -the ANSWER cohort study-
Kosuke Ebina
Toru Hirano
Yuichi Maeda
Wataru Yamamoto
Motomu Hashimoto
Koichi Murata
Tohru Takeuchi
Koji Nagai
Yonsu Son
Hideki Amuro
Akira Onishi
Sadao Jinno
Ryota Hara
Masaki Katayama
Keiichi Yamamoto
Atsushi Kumanogoh
Makoto Hirao
Clinical Rheumatology, 2020, 39 : 2563 - 2572
[6] Drug tolerability and reasons for discontinuation of seven biologics in elderly patients with rheumatoid arthritis-The ANSWER cohort study-
Ebina, Kosuke
Hashimoto, Motomu
Yamamoto, Wataru
Hirano, Toru
Hara, Ryota
Katayama, Masaki
Onishi, Akira
Nagai, Koji
Son, Yonsu
Amuro, Hideki
Yamamoto, Keiichi
Maeda, Yuichi
Murata, Koichi
Jinno, Sadao
Takeuchi, Tohru
Hirao, Makoto
Kumanogoh, Atsushi
Yoshikawa, Hideki
PLOS ONE, 2019, 14 (05):
[7] Drug tolerability and reasons for discontinuation of seven biologics in 4466 treatment courses of rheumatoid arthritis—the ANSWER cohort study
Kosuke Ebina
Motomu Hashimoto
Wataru Yamamoto
Toru Hirano
Ryota Hara
Masaki Katayama
Akira Onishi
Koji Nagai
Yonsu Son
Hideki Amuro
Keiichi Yamamoto
Yuichi Maeda
Koichi Murata
Sadao Jinno
Tohru Takeuchi
Makoto Hirao
Atsushi Kumanogoh
Hideki Yoshikawa
Arthritis Research & Therapy, 21
[8] IMPACT OF SEROPOSITIVITY ON DRUG RETENTION OF BIOLOGICS AND JAK INHIBITORS -THE ANSWER COHORT STUDY
Etani, Y.
Ebina, K.
Okita, Y.
Maeda, Y.
Tsujimoto, K.
Onishi, A.
Onizawa, H.
Okano, T.
Nishimura, K.
Yoshikawa, A.
Shiba, H.
Amuro, H.
Son, Y.
Hashimoto, M.
Okano, T.
Hara, R.
Yamamoto, W.
Kumanogoh, A.
Okada, S.
ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 1389 - 1389
[9] Drug tolerability and reasons for discontinuation of seven biologics in 4466 treatment courses of rheumatoid arthritis-the ANSWER cohort study
Ebina, Kosuke
Hashimoto, Motomu
Yamamoto, Wataru
Hirano, Toru
Hara, Ryota
Katayama, Masaki
Onishi, Akira
Nagai, Koji
Son, Yonsu
Amuro, Hideki
Yamamoto, Keiichi
Maeda, Yuichi
Murata, Koichi
Jinno, Sadao
Takeuchi, Tohru
Hirao, Makoto
Kumanogoh, Atsushi
Yoshikawa, Hideki
ARTHRITIS RESEARCH & THERAPY, 2019, 21 (1)
[10] Drug Tolerability and Discontinuation Reasons of 7 Biologics in 4466 Treatment Courses of Rheumatoid Arthritis -the Answer Cohort Study-
Ebina, Kosuke
Hirao, Makoto
Hashimoto, Motomu
Yamamoto, Wataru
Onishi, Akira
Hirano, Toru
Hara, Ryota
Katayama, Masaki
Yoshida, Shuzo
Nagai, Koji
Son, Yonsu
Amuro, Hideki
Akashi, Kengo
Murata, Koichi
Murakami, Kosaku
Yamamoto, Keiichi
Yoshikawa, Hideki
ARTHRITIS & RHEUMATOLOGY, 2018, 70

← 1 2 3 4 5 →